𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study

✍ Scribed by A. L. Lamberg; E. Horvath-Puho; S. Christensen; H. T. Sørensen


Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
129 KB
Volume
21
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Exposure to bisphosphonates and risk of
✍ Harminder Singh; Zoann Nugent; Alain Demers; Salaheddin Mahmud; Charles Bernstei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

## Abstract ## BACKGROUND: Chemoprevention is a potentially attractive strategy for decreasing the burden of colorectal cancer (CRC). Preclinical studies suggest that bisphosphonates (BPs) may have direct antitumour effects against CRC. The objective of this study was to determine the effect of ex

Use of proton pump inhibitors and risk o
✍ S. Pouwels; A. Lalmohamed; P. Souverein; C. Cooper; B. J. Veldt; H. G. Leufkens; 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 177 KB

## Summary Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causa

Oral bisphosphonates and risk of subtroc
✍ Seo Young Kim; Sebastian Schneeweiss; Jeffrey N Katz; Raisa Levin; Daniel H Solo 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 214 KB

Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi